Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michael Caruana, DPhil"'
Autor:
Jie-Bin Lew, MPH, Prof D James B St John, DMedSci, Xiang-Ming Xu, MPH, Marjolein J E Greuter, PhD, Michael Caruana, DPhil, Dayna R Cenin, MPH, Emily He, MBBS MPH, Marion Saville, MBChB, Paul Grogan, Veerle M H Coupé, PhD, Prof Karen Canfell, DPhil
Publikováno v:
The Lancet Public Health, Vol 2, Iss 7, Pp e331-e340 (2017)
Background: No assessment of the National Bowel Screening Program (NBCSP) in Australia, which considers all downstream benefits, costs, and harms, has been done. We aimed to use a comprehensive natural history model and the most recent information ab
Externí odkaz:
https://doaj.org/article/9fc564828263404bbf728f516f937e94
Autor:
Jie-Bin Lew, MPH, Kate T Simms, PhD, Megan A Smith, MPH, Michaela Hall, BAdvSc, Yoon-Jung Kang, PhD, Xiang Ming Xu, MPH, Michael Caruana, DPhil, Louiza Sofia Velentzis, PhD, Tracey Bessell, PhD, Marion Saville, MBChB, Prof Ian Hammond, MBBS, Prof Karen Canfell, DPhil
Publikováno v:
The Lancet Public Health, Vol 2, Iss 2, Pp e96-e107 (2017)
Background: Australia's National Cervical Screening Program currently recommends cytological screening every 2 years for women aged 18–69 years. Human papillomavirus (HPV) vaccination was implemented in 2007 with high population coverage, and falls
Externí odkaz:
https://doaj.org/article/d4b83604fc5646a388108ebd02762812
Autor:
Kate T Simms, DrPhD, Jean-François Laprise, PhD, Megan A Smith, MPH, Jie-Bin Lew, MPH, Michael Caruana, DPhil, Marc Brisson, ProfPhD, Karen Canfell, ProfDPhil
Publikováno v:
The Lancet Public Health, Vol 1, Iss 2, Pp e66-e75 (2016)
Summary: Background: First generation bivalent and quadrivalent human papillomavirus (HPV) vaccines have been introduced in most developed countries. A next generation nonavalent vaccine (HPV9) has become available, just as many countries are conside
Externí odkaz:
https://doaj.org/article/9a9b6e357efe4d8baff9371339479e52